Dr Alice Fabbri

MD, PhD

Member of the Charles Perkins Centre

D17 - Charles Perkins Centre
The University of Sydney

Biographical details

Dr Alice Fabbri is a postdoctoral research fellow in the School of Pharmacy based at the Charles Perkins Centre. Her work focuses on pharmaceutical policy and on corporate influences on health. She is a Medical Doctor with a specialization in Public Health.

Research interests

Dr Fabbri is interested in commercial influences on health. Her doctoral work involved an analysis of corporate influence on research and professional practice with case studies from the food and pharmaceutical industries.


Her current research projects focus on the relationship between health professionals and the pharmaceutical industry in clinical practice and on industry funding of health consumer organisations.


She is involved in an international NHMRC-funded project, “How best to protect public health: a comparative analysis of regulatory safety warnings on medicines in Australia, Canada, the European Union and the United States” whose aim is to examine the effects of national medication safety warnings on healthcare delivery and patient safety.


Dr Fabbri is a member of the Evidence, Influence and Policy Collaborative (EPIC) Research Group at the Charles Perkins Centre.

Associations

People’s Health Movement (2011-present)

Nograzie group (2008-present)

In the media

ABC Radio Darwin (October 2, 2018) Mornings. Presenter:Conor Byrne.http://www.abc.net.au/radio/darwin/programs/mornings/mornings/10304782

ABC Sydney Radio Breakfast. (September 26, 2018) Presenters: Rebecca de Unamuno and Robbie Buck. http://www.abc.net.au/radio/sydney/programs/breakfast/

The Guardian, Australia edition (September 26, 2018) Christopher Knaus: Corporate sponsorship diverts research and distorts public policy, report finds. https://www.theguardian.com/australia-news/2018/sep/26/corporate-sponsorship-diverts-research-and-distorts-public-policy-report-finds

Market Business News (September 26, 2018) David Jones: We must address industry influence on research agendas, review concludes.https://marketbusinessnews.com/industry-influence-research-agendas/188067/

RACGP (September 26, 2018) Amanda Lyons: Anything to declare? Corporate influence in medical research. https://www.racgp.org.au/newsGP/Professional/Anything-to-declare-Corporate-influence-in-medical

BuzzFeed.News (July 25, 2018) Elfy Scott: Organisations That Inform Patients And Influence Policy Aren't Disclosing Their Industry Funding. https://www.buzzfeed.com/elfyscott/organisations-that-inform-patients-and-influence-policy?utm_term=.apWozG5eO#.ieZm0xWYX

The Sydney Morning Herald (January 4, 2018) Esther Han: Alarm over drug companies' extravagant spending and influence on doctors. https://amp.smh.com.au/national/alarm-over-drug-companies-extravagant-spending-and-influence-on-doctors-20180110-h0g692.html

Keywords

Conflict of interest; Bias; pharmaceutical policy

Selected grants

2018

  • Mapping money and medicine: Geographical variation in pharmaceutical industry funding to healthcare professionals and use of medicines in Australia; Karanges E, Mintzes B, Bero L, Fabbri A, Parker L; University of Sydney, Faculty of Pharmacy/Research Support Grant.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Martino, A., Bodini, C., Di Girolamo, C., Fabbri, A. (2018). Dall'in-formazione all'azione [From information to action]. InFormAzione per cambiare: 4� Rapporto dell'OsservatorioItaliano sulla Salute Globale [Information to change: 4th Report of the Italian Observatory on Global Health], (pp. 69-82). Pisa: Edizioni ETS.
  • Fabbri, A. (2016). CONFLITTO DI INTERESSI TRA MEDICI E INDUSTRIA FARMACEUTICA: un'esperienza di ricerca azione partecipativa con gli studentidi Medicina [CONFLICT OF INTERESTS BETWEEN PHYSICIANS AND PHARMACEUTICAL INDUSTRY: a participatory research experience with medical students]. In Tulio Batista Franco, & Ricardo Burg Ceccim (Eds.), PRASSI IN SALUTE GLOBALE: AzioniCondivise Tra Brasile e Italia [PRACTICE IN GLOBAL HEALTH: Actions Shared between Brazil and Italy], (pp. 170-192). Bologna: Salute Collettiva e Cooperazione Internazionale.
  • Di Girolamo, C., Fabbri, A. (2013). Le malattie non trasmissibili tra salute pubblica e interessi privati: l'affermarsi del modello multistakeholder [Non-communicable diseases between public health and private interests: the emergence of the multi-stakeholder model]. In A. Cattaneo, V. Confalonieri, N. Dentico, E. Missoni, A. Siniscalchi (Eds.), OMS e diritto alla salute: quale futuro [WHO and the right to health: what future], (pp. 125-135). Italy: Osservatorio Italiano sulla Salute Globale.
  • Bodini, C., Di Girolamo, C., Fabbri, A., Resti, C. (2011). L'insegnamento della salute globale al personale sanitario [The teaching of global health to health personnel]. InFormAzione per cambiare: 4� Rapporto dell'OsservatorioItaliano sulla Salute Globale [Information to change: 4th Report of the Italian Observatory on Global Health], (pp. 21-26). Pisa: Edizioni ETS.

Journals

  • Mintzes, B., Swandari, S., Fabbri, A., Grundy, Q., Moynihan, R., Bero, L. (2018). Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study. BMJ Open, 8(2), e019027. [More Information]
  • Fabbri, A., Holland, T., Bero, L. (2018). Food industry sponsorship of academic research: investigating commercial bias in the research agenda. Public Health Nutrition, 21(18), 3422-3430. [More Information]
  • de Rezende, L., Rey Lopez, J., de Sa, T., Chartres, N., Fabbri, A., Powell, L., Stamatakis, E., Bero, L. (2018). Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality. PLoS Biology, 16(6), e2005761. [More Information]
  • Fabbri, A., Santos, A., Mezinska, S., Mulinari, S., Mintzes, B. (2018). Sunshine policies and murky shadows in Europe: Disclosure of pharmaceutical industry payments to health professionals in nine European countries. International Journal of Health Policy and Management, 7(6), 504-509. [More Information]
  • Fabbri, A., Lai, A., Grundy, Q., Bero, L. (2018). The influence of industry sponsorship on the research agenda: A scoping review. American Journal of Public Health, 108(11), e9-e16. [More Information]
  • Bero, L., Chartres, N., Diong, J., Fabbri, A., Ghersi, D., Lam, J., Lau, A., McDonald, S., Mintzes, B., Sutton, P., Turton, J., et al (2018). The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures. Systematic Reviews, 7(1), 1-11. [More Information]
  • Fabbri, A., Grundy, Q., Mintzes, B., Swandari, S., Moynihan, R., Walkom, E., Bero, L. (2017). A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia. BMJ Open, 7(6), 1-8. [More Information]
  • Fabbri, A., Chartres, N., Bero, L. (2017). Study sponsorship and the nutrition research agenda: analysis of cohort studies examining the association between nutrition and obesity. Public Health Nutrition, 20(17), 3193-3199. [More Information]
  • Fabbri, A., Chartres, N., Scrinis, G., Bero, L. (2017). Study sponsorship and the nutrition research agenda: Analysis of randomized controlled trials included in systematic reviews of nutrition interventions to address obesity. Public Health Nutrition, 20(7), 1306-1313. [More Information]
  • Chartres, N., Fabbri, A., Bero, L. (2016). Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis. JAMA Internal Medicine, 176(12), 1769-1777. [More Information]
  • Fabbri, A., Gregoraci, G., Tedesco, D., Ferretti, F., Gilardi, F., Iemmi, D., Lisi, C., Lorusso, A., Natali, F., et al (2016). Conflict of interest between professional medical societies and industry: A cross-sectional study of Italian medical societies' websites. BMJ Open, 6(6), 1-8. [More Information]
  • Grundy, Q., Fabbri, A., Mintzes, B., Swandari, S., Bero, L. (2016). The inclusion of nurses in pharmaceutical industry-sponsored events: Guess who is also coming to dinner? JAMA Internal Medicine, 176(11), 1718-1720. [More Information]
  • Bodini, C., Civitelli, G., Fabbri, A., Lorusso, A., Maranini, N., Parisotto, M., Rinaldi, A. (2015). Rethinking health education. A debate organized by the Italian Network for Global Health Education [Ripensare la formazione in salute. Un dibattito a cura della Rete Italiana per l'Insegnamento della Salute Globale]. Quaderni ACP, 22(3), 127-129.

2018

  • Martino, A., Bodini, C., Di Girolamo, C., Fabbri, A. (2018). Dall'in-formazione all'azione [From information to action]. InFormAzione per cambiare: 4� Rapporto dell'OsservatorioItaliano sulla Salute Globale [Information to change: 4th Report of the Italian Observatory on Global Health], (pp. 69-82). Pisa: Edizioni ETS.
  • Mintzes, B., Swandari, S., Fabbri, A., Grundy, Q., Moynihan, R., Bero, L. (2018). Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study. BMJ Open, 8(2), e019027. [More Information]
  • Fabbri, A., Holland, T., Bero, L. (2018). Food industry sponsorship of academic research: investigating commercial bias in the research agenda. Public Health Nutrition, 21(18), 3422-3430. [More Information]
  • de Rezende, L., Rey Lopez, J., de Sa, T., Chartres, N., Fabbri, A., Powell, L., Stamatakis, E., Bero, L. (2018). Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality. PLoS Biology, 16(6), e2005761. [More Information]
  • Fabbri, A., Santos, A., Mezinska, S., Mulinari, S., Mintzes, B. (2018). Sunshine policies and murky shadows in Europe: Disclosure of pharmaceutical industry payments to health professionals in nine European countries. International Journal of Health Policy and Management, 7(6), 504-509. [More Information]
  • Fabbri, A., Lai, A., Grundy, Q., Bero, L. (2018). The influence of industry sponsorship on the research agenda: A scoping review. American Journal of Public Health, 108(11), e9-e16. [More Information]
  • Bero, L., Chartres, N., Diong, J., Fabbri, A., Ghersi, D., Lam, J., Lau, A., McDonald, S., Mintzes, B., Sutton, P., Turton, J., et al (2018). The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures. Systematic Reviews, 7(1), 1-11. [More Information]

2017

  • Fabbri, A., Grundy, Q., Mintzes, B., Swandari, S., Moynihan, R., Walkom, E., Bero, L. (2017). A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia. BMJ Open, 7(6), 1-8. [More Information]
  • Fabbri, A., Chartres, N., Bero, L. (2017). Study sponsorship and the nutrition research agenda: analysis of cohort studies examining the association between nutrition and obesity. Public Health Nutrition, 20(17), 3193-3199. [More Information]
  • Fabbri, A., Chartres, N., Scrinis, G., Bero, L. (2017). Study sponsorship and the nutrition research agenda: Analysis of randomized controlled trials included in systematic reviews of nutrition interventions to address obesity. Public Health Nutrition, 20(7), 1306-1313. [More Information]

2016

  • Chartres, N., Fabbri, A., Bero, L. (2016). Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis. JAMA Internal Medicine, 176(12), 1769-1777. [More Information]
  • Fabbri, A., Gregoraci, G., Tedesco, D., Ferretti, F., Gilardi, F., Iemmi, D., Lisi, C., Lorusso, A., Natali, F., et al (2016). Conflict of interest between professional medical societies and industry: A cross-sectional study of Italian medical societies' websites. BMJ Open, 6(6), 1-8. [More Information]
  • Fabbri, A. (2016). CONFLITTO DI INTERESSI TRA MEDICI E INDUSTRIA FARMACEUTICA: un'esperienza di ricerca azione partecipativa con gli studentidi Medicina [CONFLICT OF INTERESTS BETWEEN PHYSICIANS AND PHARMACEUTICAL INDUSTRY: a participatory research experience with medical students]. In Tulio Batista Franco, & Ricardo Burg Ceccim (Eds.), PRASSI IN SALUTE GLOBALE: AzioniCondivise Tra Brasile e Italia [PRACTICE IN GLOBAL HEALTH: Actions Shared between Brazil and Italy], (pp. 170-192). Bologna: Salute Collettiva e Cooperazione Internazionale.
  • Grundy, Q., Fabbri, A., Mintzes, B., Swandari, S., Bero, L. (2016). The inclusion of nurses in pharmaceutical industry-sponsored events: Guess who is also coming to dinner? JAMA Internal Medicine, 176(11), 1718-1720. [More Information]

2015

  • Bodini, C., Civitelli, G., Fabbri, A., Lorusso, A., Maranini, N., Parisotto, M., Rinaldi, A. (2015). Rethinking health education. A debate organized by the Italian Network for Global Health Education [Ripensare la formazione in salute. Un dibattito a cura della Rete Italiana per l'Insegnamento della Salute Globale]. Quaderni ACP, 22(3), 127-129.

2013

  • Di Girolamo, C., Fabbri, A. (2013). Le malattie non trasmissibili tra salute pubblica e interessi privati: l'affermarsi del modello multistakeholder [Non-communicable diseases between public health and private interests: the emergence of the multi-stakeholder model]. In A. Cattaneo, V. Confalonieri, N. Dentico, E. Missoni, A. Siniscalchi (Eds.), OMS e diritto alla salute: quale futuro [WHO and the right to health: what future], (pp. 125-135). Italy: Osservatorio Italiano sulla Salute Globale.

2011

  • Bodini, C., Di Girolamo, C., Fabbri, A., Resti, C. (2011). L'insegnamento della salute globale al personale sanitario [The teaching of global health to health personnel]. InFormAzione per cambiare: 4� Rapporto dell'OsservatorioItaliano sulla Salute Globale [Information to change: 4th Report of the Italian Observatory on Global Health], (pp. 21-26). Pisa: Edizioni ETS.

For support on your academic profile contact .